N. Monnier et al., OCRL1 mutation analysis in French Lowe syndrome patients: Implications formolecular diagnosis strategy and genetic counseling, HUM MUTAT, 16(2), 2000, pp. 157-165
The oculocerebrorenal syndrome of Lowe (OCRL) is a rare X-linked recessivel
y inherited disease characterized by a severe pleiotropic phenotype includi
ng mental retardation, bilateral congenital cataract, and renal Fanconi syn
drome. The gene responsible for OCRL encodes an inositol polyphosphate-5-ph
osphatase. We performed mutation analysis in 36 families and characterized
27 new mutations with two of them being recurrent mutations. The panel of m
utations consisted of 27 truncating mutations (frameshift, nonsense, splice
site mutations, and large genomic deletions), one in frame deletion, and s
ix missense mutations. The four large genomic deletions occurred in the fir
st half of the gene, whereas all the remaining mutations took place in the
second part of the gene and were concentrated in a few exons. This distribu
tion may be of interest in terms of screening strategy when looking for unk
nown mutations, Haplotyping of the families was performed to analyze segreg
ation of the mutated loci, and revealed a somatic mosaicism in one family T
his is the second case of mosaicism we characterized in a total panel of 44
unrelated families affected by Lowe's syndrome. Considering the low number
of families investigated, it appeared that somatic and germinal mosaicisms
are quite common in this disease and must be taken into account for geneti
c counseling. Hum Mutat 16:157-165, 2000. (C) 2000 Wiley Liss, Inc.